Furthermore, pathway enrichment analysis based on the predicted metabolite sets library of differentially abundant metabolites identified by supernatant-targeted metabolomics revealed that TACC3 reprograms PUFA metabolism within HCC cells, thereby altering PUFA composition in the TME (Supplementary Fig. 5f). Here, TACC3 is linked to hepatocellular carcinoma.